期刊文献+

穿膜肽HIV-TAT与呼吸道合胞病毒G蛋白片段G1及CTL表位融合蛋白的表达及纯化

Expression and Purification of Fusion Protein Containing Cell-penetrating Peptide HIV-TAT as well as Glycoprotein G1 and CTL Epitope of Respiratory Syncytial Virus
在线阅读 下载PDF
导出
摘要 目的在大肠杆菌中表达含穿膜肽HIV-TAT与呼吸道合胞病毒(RSV)G蛋白片段G1及CTL表位的融合蛋白,并进行纯化。方法以质粒pET-G1F/M2为模板,扩增含TAT、RSVG蛋白片段G1和CTL表位F/M2的融合基因片段,与原核表达质粒pET-His连接,构建融合表达质粒pET-TAT-G1F/M2,转化E.coli BL21(DE3)plysS进行诱导表达,采用Ni2+螯合亲和层析法纯化经尿素变性的包涵体,梯度透析复性纯化的目的蛋白,并进行Westernblot鉴定。结果在E.coli中可高效表达重组蛋白TAT-G1F/M2,表达量占菌体总蛋白的30%以上,目的蛋白主要存在于包涵体中。经变性、纯化、复性可获得高纯度(>95%)特异性的TAT-G1F/M2蛋白。结论已在大肠杆菌中成功表达了融合蛋白TAT-G1F/M2,为进一步进行RSV体内体外免疫学研究奠定了基础。 Objective To express the fusion protein containing Cell-penetrating peptide HIV-TAT as well as the glycoprotein G1 and CTL epitope of respiratory syncytial virus (RSV) in E. coli and purify the expressed product. Methods Amplify the fusion gene encoding HIV-TAT as well as G1 protein and CTL epitope F/M2 of RSV using plasmid pET-G1F/M2 as a template and insert into prokaryotic expression vector pET-His. Transform the constructed recombinant plasmid pET-TAT-G1F/M2 to E. coli BL21 (DE3)plysS for expression under induction of IPTG. The expressed product in a form of inclusion body was denaturalized with urea, purified by nickel ion chelate affinity chromatography, renaturalized by gradient dialysis and identified by Western blot. Results The recombinant fusion protein TAT-G1F/M2 expressed in E. coli mainly existed in inclusion body and contained more than 30% of total somatic protein. After denaturalization, purification and renaturalization, the expressed protein reached a purity of more than 95%. Conclusion Fusion protein TAT-G1F/M2 was successfully expressed in E. coli, which laid a foundation of in vitro and in vivo immunological study on RSV.
出处 《中国生物制品学杂志》 CAS CSCD 2008年第11期951-953,共3页 Chinese Journal of Biologicals
基金 国家自然科学基金资助项目(30671923)
关键词 呼吸道合胞病毒 G蛋白 CTL表位 穿膜肽 融合蛋白 表达 纯化 Respiratory syncytial virus Glycoprotein CTL epitope Cell-penetrating peptide Fusion protein Expression Purification
作者简介 通讯作者:梅兴国,E-mail:newdds@126.com
  • 相关文献

参考文献9

  • 1Groothuis JR, Nishida H. Prevention of respiratory syncytial virus infections in high- risk infants by monoclonal antibody(palivizumab). Pediatr Int, 2002, 44(3): 235- 241.
  • 2De Waal L, Power UF, Ytiksel S, et al. Evaluation of BBG2Na in infant macaques: specific immune responses after vaccination and RSV challenge. Vaccine, 2004, 22(8 ): 915-922.
  • 3龚伟,范昌发,曾瑞红,梅兴国.含有RSV G蛋白片段和CTL表位融合蛋白的表达及纯化[J].军事医学科学院院刊,2005,29(2):120-123. 被引量:2
  • 4曾瑞红,梅兴国,龚伟,亓晓温.RSV CTL表位与G蛋白片段的融合表达对G蛋白片段诱导的免疫应答的调节作用[J].中国免疫学杂志,2007,23(5):387-390. 被引量:9
  • 5Zeng RH, Gong W, Fan CF, et al. Induction of balanced immunity in BALB/c mice by vaccination with a recombinant fusion protein containing a respiratory syncytial virus G protein fragment and a CTL epitope. Vaccine, 2006, 24(7): 941-947.
  • 6Shibagaki N, Udey MC. Dendritic cells transduced with protein antigens induce cytotoxic lymphocytes and elicit antitumor immunity. J Immunol, 2002, 168(5): 2393-2401.
  • 7Shibagaki N, Udey MC. Dendritic cells transduced with TAT protein transduction domain-containing tyrosinase-related protein 2 vaccinate against murine melanoma. Eur J Immunol, 2003, 33(4): 850-860.
  • 8Gupta B, Levehenko TS, Torchilin VP. Intracellular delivery of large molecules and small particles by cell-penetrating proteins and peptides. Adv Drug Deliv Rev, 2005, 57(4): 637-651.
  • 9Luhrs P, Schmidt W, Kutil R, et al. Induction of specific immune responses by polycation-bBased vaccines. J Immunol, 2002, 169 (9): 5217-5226.

二级参考文献16

  • 1叶枫,陈怀增,谢幸,叶大风.卵巢癌细胞株冻融抗原负载的树突状细胞诱导CTL抗卵巢癌免疫应答的体外研究[J].中华微生物学和免疫学杂志,2004,24(12):964-967. 被引量:9
  • 2耿学辉,王之梁,钱渊,朱汝南,邓洁,杜金林,朱宗涵.呼吸道合胞病毒北京地区分离株G蛋白的基因分析[J].病毒学报,1996,12(4):317-322. 被引量:10
  • 3Simard C, Nadon F, Seguin C, et al. Evidence that the amino acid region 124-203 of glycoprotein G from the respiratory syncytial virus (RSV) constitutes a major part of the polypeptide domain that is involved in the protection against RSV infection[J]. Antiviral Res, 1995, 28(4): 303-315.
  • 4Kulkarni AB, Morse HC, Bennink JR, et al. Immunization of mice with vaccinia virus-M2 recombinant induces epitope-specific and cross-reactive Kd-restricted CD8+ cytotoxic T cells[J]. J Virol, 1993, 67(7): 4086-4092.
  • 5Steward MW. The development of a mimotope-based synthetic peptide vaccine against respiratory syncytial virus[J]. Biologicals, 2001, 29(3-4): 215-219.
  • 6Hsu SC, Chargelegue D, Obeid OE, et al. Synergistic effect of immunization with a peptide cocktail inducing antibody, helper and cytotoxic T-cell responses on protection against respiratory syncytial virus[J]. J Gen Virol, 1999, 80(Pt 6): 1401-1405.
  • 7Groothuis JR, Nishida H. Prevention of respiratory syncytial virus infections in high-risk infants by monoclonal antibody (palivizumab)[J]. Pediatr Int, 2002, 44(3): 235-241.
  • 8Paes BA. Current strategies in the prevention of respiratory syncytial virus disease[J]. Paediatr Respir Rev, 2003, 4(1): 21-27.
  • 9Lelievre D, Hsu SC, Daubos P, et al. Structural properties of chimeric peptides containing a T-cell epitope linked to a fusion peptide and their importance for in vivo induction of cytotoxic T-cell responses[J]. Eur J Biochem, 1997, 249(3): 895-904.
  • 10Meissner H C.Economic impact of viral respiratory disease in children[J].J Pediatr,1994;24:s17-s21.

共引文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部